1. Home
  2. AVO vs LTGO Comparison

AVO vs LTGO Comparison

Compare AVO & LTGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mission Produce Inc.

AVO

Mission Produce Inc.

HOLD

Current Price

$11.69

Market Cap

1.0B

ML Signal

HOLD

LTGO

Latigo Biotherapeutics Inc. Common Stock

N/A

Current Price

$15.03

Market Cap

1.2B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
AVO
LTGO
Founded
1983
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Sector
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
AVO
LTGO
Price
$11.69
$15.03
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$16.50
★ $52.25
AVG Volume (30 Days)
★ 922.9K
269.1K
Earning Date
09-08-2026
11-19-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 1.92
N/A
EPS
★ N/A
N/A
Revenue
★ $1,391,200,000.00
N/A
Revenue This Year
$4.60
N/A
Revenue Next Year
$16.03
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 12.68
N/A
52 Week Low
$10.07
$13.50
52 Week High
$15.53
$25.93

Technical Indicators

Market Signals
Indicator
AVO
LTGO
Relative Strength Index (RSI) 39.15 41.92
Support Level $10.22 $14.05
Resistance Level $13.35 $16.56
Average True Range (ATR) 0.49 1.25
MACD -0.04 0.23
Stochastic Oscillator 38.41 39.36

Price Performance

Historical Comparison
AVO
LTGO

About AVO Mission Produce Inc.

Mission Produce Inc produces, packs, and distributes mainly Hass avocados to retail, wholesale, and food service customers, offering pre-ripe and ripened fruit tailored to customer specifications through its network of ripening facilities. The Company operates through three segments: Marketing & Distribution, which sources and distributes fruit globally and generates the majority of revenue; International Farming, which owns and operates avocado orchards and supplies fruit mainly to Marketing & Distribution, with operations principally in Peru and Guatemala; and Blueberries, which farms blueberries sold under an exclusive marketing agreement. The Company's operations span Peru, the United States, Guatemala, Mexico, Europe, and Canada.

About LTGO Latigo Biotherapeutics Inc. Common Stock

Latigo Biotherapeutics Inc is a clinical-stage biotechnology company focused on developing non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its flagship product candidates, LTG-001 and LTG-321, are oral Nav1.8 inhibitors being developed for the treatment of acute pain. The company is also developing additional Nav1.8 inhibitor candidates using alternative formulations and delivery approaches.

Share on Social Networks: